Back to bill feed
H.R. 10919 (119th Congress)Committee
Sign in to get alerts

To amend title III of the Public Health Service Act to ensure that certain safety net providers are not required to pay more than the 340B ceiling price for covered outpatient drugs at the time of purchase.

Read the record. Not the rhetoric.

See how your representatives voted on this bill.

DeepSyte matches this bill to the issues you care about and shows whether your reps' votes line up — not party, not press releases. Take the 2-minute values quiz to see your alignment.

Alignment with your views

Sign in and take the values quiz to see how this bill lines up with what you've said.

Summary

AI-generated summary — verify against full text

Based on the bill's title, this legislation would amend Title III of the Public Health Service Act to specify that certain safety net providers are not required to pay more than the 340B ceiling price for covered outpatient drugs at the time of purchase. The 340B program requires drug manufacturers to offer discounted prices to eligible safety net providers, and the bill's title indicates it would address the price safety net providers pay at the point of sale. Full bill text was not available, so the specific eligible entities, mechanisms, and enforcement provisions cannot be confirmed.

Values analysis

Sign in and take the values quiz to get a personalized read on how this bill lines up with your positions.

How your representatives voted

Sign in to see how your representatives voted on this bill.